MCENANY PATRICK J

CIK 00009299852 companiesCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0000929985

Recent Transactions

50 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-08−3,534→ 1,878,282 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08+3,534→ 4,152,011 total
Gift
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-12-01−45,000→ 4,328,477 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−1,775→ 1,881,816 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+1,775→ 4,283,477 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+34,921→ 1,873,051 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+10,540→ 1,883,591 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-06-09$26.11/sh−171,748→ 4,281,702 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-06-06$25.95/sh−28,252→ 4,453,450 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−3,533→ 1,838,130 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+3,533→ 4,481,702 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21+5,327→ 1,841,663 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+43,591→ 1,836,336 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-20$3.54/sh+72,500→ 4,550,669 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-20−72,500→ 1,792,745 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-20$21.29/sh−72,500→ 4,478,169 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-19$21.19/sh−98,345→ 4,478,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-19−98,345→ 1,865,245 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-19$3.54/sh+98,345→ 4,576,514 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-14$21.75/sh−44,655→ 4,478,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-14$3.54/sh+44,655→ 4,522,824 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-14−44,655→ 1,963,590 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-13−92,500→ 2,008,245 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-13$3.54/sh+92,500→ 4,570,669 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-13$22.98/sh−92,500→ 4,478,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-12$4.01/sh+70,000→ 4,548,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-12−70,000→ 2,292,745 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-12−192,000→ 2,100,745 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-12$23.20/sh−192,000→ 4,478,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-12$3.54/sh+192,000→ 4,670,169 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-12$23.42/sh−70,000→ 4,478,169 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-11$23.55/sh−230,000→ 4,478,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-11$4.01/sh+230,000→ 4,708,169 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-11−230,000→ 2,362,745 total
Gift
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-08-22−5,100→ 4,478,169 total
Gift
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-08-15−45,000→ 4,483,269 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-01-30−116,667→ 2,592,745 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-01-30−26,333→ 2,709,412 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-01-30+26,333→ 4,411,589 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-01-30+116,667→ 4,528,256 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-01-02$1.13/sh+250,000→ 4,385,256 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-01-02−250,000→ 2,735,745 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27+26,333→ 4,145,618 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−26,333→ 2,985,745 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27−10,362→ 4,135,256 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-08+10,601→ 3,012,078 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+73,810→ 3,001,477 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-05-16−173,849→ 2,927,667 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-05-16$0.79/sh+173,849→ 4,119,285 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-05-15$0.79/sh+26,151→ 3,971,587 total

Companies

Recent Filings

Address

355 ALHAMBRA CIRCLE, SUITE 1370

CORAL GABLES, FL, 33134

View on SEC.gov